Evidence map›Paper›PMID 40295828›Full record

ArticleLeukemia2025

Prognostic impact of clonal representation of myelodysplasia-related gene mutations in acute myeloid leukemia.

Rabea Mecklenbrauck, Nora Borchert, Razif Gabdoulline, Piroska Poll, Carolin Funke, Maximilian Brandes, Louisa-Kristin Dallmann, Walter Fiedler, Jürgen Krauter, Arne Trummer and 14 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. AML, Myelodysplasia-Related: Beyond Classification-Toward Precision Decision-Making.Mediterranean journal of hematology and infectious diseases · 2026
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Rabea MecklenbrauckDepartment of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Nora BorchertDepartment of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Razif GabdoullineDepartment of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Piroska PollDepartment of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Carolin FunkeDepartment of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Maximilian BrandesDepartment of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Louisa-Kristin DallmannDepartment of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Walter FiedlerDepartment of Internal Medicine, University Hospital Hamburg Eppendorf, Hamburg, Germany.
Jürgen KrauterDepartment of Hematology and Oncology, Municipal Hospital Braunschweig, Braunschweig, Germany.
Arne TrummerDepartment of Hematology, Oncology and Palliative Care, Heidekreisklinikum, Walsrode, Germany.
Bernd HertensteinDepartment of Internal Medicine I, Hospital Bremen-Mitte, Bremen, Germany.
Martin MüllerDepartment of Hematology, Oncology and Immunology, Hospital Siloah, Hannover, Germany.
Michael LübbertDepartment of Internal Medicine I, University Hospital Freiburg, Freiburg, Germany.ORCID http://orcid.org/0000-0003-1186-1650
Monika SchwalenbergDepartment of Hematology, Oncology and Palliative Care, Hospital Lüdenscheid, Lüdenscheid, Germany.
Andreas VossDepartment of Oncology and Hematology, Klinikum Oldenburg, Oldenburg, Germany.ORCID http://orcid.org/0000-0001-9647-5024
Nataliya Di DonatoInstitute of Human Genetics, Hannover Medical School, Hannover, Germany.
Anke BergmannInstitute of Human Genetics, Hannover Medical School, Hannover, Germany.ORCID http://orcid.org/0000-0002-1367-2725
Verena GaidzikDepartment of Internal Medicine III, University Hospital Ulm, Ulm, Germany.ORCID http://orcid.org/0000-0001-6530-3406
Konstanze DöhnerDepartment of Internal Medicine III, University Hospital Ulm, Ulm, Germany.ORCID http://orcid.org/0000-0002-2261-9862
Hartmut DöhnerDepartment of Internal Medicine III, University Hospital Ulm, Ulm, Germany.ORCID http://orcid.org/0000-0003-2116-5536
Arnold GanserDepartment of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Florian H HeidelDepartment of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.ORCID http://orcid.org/0000-0003-2438-1955
Felicitas R TholDepartment of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.ORCID http://orcid.org/0000-0001-5848-6152
Michael HeuserDepartment of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany. heuser.michael@mh-hannover.de.ORCID http://orcid.org/0000-0001-5318-9044

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) HE6233/15-1 and HE6233/16-1Deutsche Krebshilfe (German Cancer Aid) 70115737
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40295828
PMCPMC12208903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.